Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for PITOLISANT HYDROCHLORIDE
- Pitolisant Effects on Affect and Cognition Exploratory Study (PEACE Study)
- Pitolisant in Refractory Restless Legs Syndrome
- An Open-Label Study to Evaluate the Long-Term Safety and Effectiveness of Pitolisant in Adult Patients With Idiopathic Hypersomnia
- A Clinical Study to Evaluate the Efficacy and Safety of Pitolisant in the Treatment of EDS in Patients With OSA
- A Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Efficacy of Pitolisant in Adult Patients With Idiopathic Hypersomnia
- Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1
- Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers
- A Phase 2 Study to Evaluate the Safety and Efficacy of Pitolisant in Patients With Prader-Willi Syndrome, Followed by an Open Label Extension
- Insulin Tolerance Test Study in Patients With Type 1 Diabetes
- Determination the Abuse Potential of Pitolisant in Healthy, Non-Dependent Recreational Stimulant Users
- Pitolisant (BF2.649) in the Treatment of Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnoea Syndrome, Treated or Not by Nasal Continuous Positive Airway Pressure, But Still Complaining of Excessive Daytime Sleepiness
- Study to Assess the Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]-Pitolisant in Healthy Male Volunteers
- A Trial Evaluating Pitolisant (BF2.649) in Alcohol Use Disorder Treatment
- Pitolisant (BF2.649) in the Treatment of EDS in Patients With OSA
- Efficacy and Safety of Pitolisant in Pediatric Narcoleptic Patients With or Without Cataplexy, Double-blind Study Followed by a Prolonged Open-label Period
- Pitolisant to Assess Weekly Frequency of Cataplexy Attacks and EDS in Narcoleptic Patients (HARMONY CTP)
- Patient Narcoleptic Treated With BF2.649 (Pitolisant) in add-on to Sodium Oxybate (HARMONY IV)
- Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.
- Dose-range Finding Study of BF2.649 Effect on Patients With Obstructive Sleep Apnea (OSA)
- Pharmacokinetics of BF2.649 in Renal Impairment
- Long Term Open Label Study in Narcolepsy With BF2.649 (Pitolisant)
- BF2.649 in Patients With OSA, Still Complaining of EDS and Refusing to be Treated by CPAP.
- BF2.649 in Patients With OSA and Treated by CPAP But Still Complaining of EDS
- Efficacy and Safety Study of BF2.649 and BF2.649 Add on Modafinil on Cataplexy in Patients With Narcolespy
- Efficacy and Safety Study of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy
- Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease
- Efficacy and Safety of BF2.649 in Excessive Daytime Sleepiness (EDS) in Parkinson's Disease
- Dose Range Finding Study of BF2.649 Versus Placebo to Treat Excessive Daytime Sleepiness in Parkinson's Disease Patients
Clinical trials list
click for details